"positive breast cancer" trang 2 - tải miễn phí từ tailieunhanh
MicroRNA alterations in ALDH positive mammary epithelial cells: A crucial contributing factor towards breast cancer risk reduction in case of early pregnancy

MicroRNA alterations in ALDH positive mammary epithelial cells: A crucial contributing factor towards breast cancer risk reduction in case of early pregnancy
13    35    1
Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer

Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer
15    63    1
Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer

Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
17    34    1
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study
7    56    3
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis

T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis
7    25    1
Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer

Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer
17    22    1
CDK4/6 inhibitors, PI3K/mTOR inhibitors, and HDAC inhibitors as second-line treatments for hormone receptor-positive, HER2-negative advanced breast cancer: A network meta-analysis

CDK4/6 inhibitors, PI3K/mTOR inhibitors, and HDAC inhibitors as second-line treatments for hormone receptor-positive, HER2-negative advanced breast cancer: A network meta-analysis
11    1    1
Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: A multicenter real-world study in the northwest of China

Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: A multicenter real-world study in the northwest of China
13    6    1
The experiences and perceptions of female breast cancer patients regarding weight management during and after treatment for oestrogen-receptor positive disease: A qualitative study

The experiences and perceptions of female breast cancer patients regarding weight management during and after treatment for oestrogen-receptor positive disease: A qualitative study
13    8    1
Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer
10    72    0
Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: Study protocol for a randomized controlled trial

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: Study protocol for a randomized controlled trial
7    54    1
PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells

PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells
11    49    1
The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients

The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
8    51    1
Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein

Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein
11    85    1
Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells

Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells
12    18    1
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
11    1    1
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR+) breast cancer

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR+) breast cancer
9    1    1
Co-designed weight management intervention for women recovering from oestrogen-receptor positive breast cancer

Co-designed weight management intervention for women recovering from oestrogen-receptor positive breast cancer
14    2    1
Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: Retrospective analysis from Leeds Cancer Centre

Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: Retrospective analysis from Leeds Cancer Centre
12    81    0
Factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia: A cross-sectional study

Factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia: A cross-sectional study
10    11    1